Get's Al Shifa

27/09/2026

Orfoxen (Orforglipron) Tablets, 0.8 mg, 2.5 mg & 5.5 mg
An oral GLP-1 receptor agonist studied and used for weight management, helping reduce excess body weight when used with a reduced-calorie diet and physical activity.

Available strengths: 0.8 mg | 2.5 mg | 5.5 mg — 30 tablets.
Use only under appropriate medical supervision and according to the approved indication in the destination country.

Authentic Medicine Supplier Worldwide with Quality Pharmaceutical Products For Professional Sourcing.

WhatsApp us : +8801575308158

25/09/2026

25/09/2026

Pemitinib 13.5 Mg, PEMIGATINIB, Targeted Oncology Therapy

A targeted FGFR inhibitor used for selected patients with FGFR2-altered cholangiocarcinoma and FGFR1-rearranged myeloid/lymphoid neoplasms.
Rx Only | Specialist supervision required.

For Inquiry WhatsApp: +8801575308158

22/09/2026

, , ,

22/09/2026

dcennbd.com
💡 Looking for Advanced Targeted Cancer Treatment? Discover LuciErlo (Erlotinib 150mg)! 💊
​In the fight against advanced cancer, precision medicine makes all the difference. LuciErlo is formulated to give patients a stronger, targeted approach to cancer care.

​🌟 Key Benefits That Make a Difference:
✅ Direct EGFR Targeting: Blocks specific proteins responsible for cancer growth.
✅ Proven Effectiveness: Trusted worldwide for Non-Small Cell Lung Cancer (NSCLC).
✅ Combination Power: Essential therapy paired with Gemcitabine for Pancreatic Cancer treatment.
✅ Quality of Life: Advanced targeted action designed for effective disease management.

​📌 Note: This is a prescription-only medication (Rx) to be used under expert medical supervision.

WhatsApp Us For Inquiry: 01575-308158

21/09/2026

Are you looking for a targeted therapy product for Advanced Kidney Cancer / RCC?

💊 LUCIAXI® 5 mg
Axitinib Tablets | 60 Tablets | Rx Only
LuciAXI® 5 mg contains Axitinib, a targeted tyrosine-kinase inhibitor used in the treatment of advanced renal cell carcinoma (RCC), a type of kidney cancer.

🎯 MAIN THERAPEUTIC USE
Advanced Renal Cell Carcinoma (RCC)
Axitinib is used in appropriate advanced RCC treatment settings, including certain combination regimens and, depending on the indication, after previous systemic therapy.

💎 PRODUCT VALUE
✔️ Specialized oncology molecule
✔️ VEGFR-targeted therapy
✔️ Established RCC treatment category
✔️ Oral tablet formulation
✔️ 5 mg strength
✔️ 60-tablet pack

🌍 For Pharmaceutical Importers, Distributors, Wholesalers & Oncology Buyers
Looking to add Axitinib to your oncology portfolio?

📩 Contact us for product availability, quotation and B2B supply information.

Gets Al Shifa Is Best Option For.
Contact Us on WhatsApp: 01575-308158

:

06/09/2026

Enjoy the videos and music you love, upload original content, and share it all with friends, family, and the world on YouTube.

03/09/2026

Rulicent 10 — ( ) 10 mg

⚕️ Important Safety Information
Prescription-only medicine. Use strictly under the supervision of a qualified physician.

Ruxolitinib may reduce platelet, hemoglobin, and white blood cell counts. Regular blood tests, including CBC, may be required.

It may increase the risk of serious infections. Seek medical attention for fever, persistent cough, or other signs of infection.

Do not stop treatment suddenly unless advised by your doctor, as symptoms may worsen or return.
Tell your doctor about any existing liver or kidney problems, infections, or other medicines you are taking.
The appropriate dose and treatment duration depend on the patient's condition and laboratory results.

💊 Main Uses:
Ruxolitinib is primarily used under specialist medical supervision for:
1. Myelofibrosis (MF)
Helps control symptoms and disease-related complications in patients with intermediate- or high-risk myelofibrosis.
2. Polycythemia Vera (PV)
Used in certain adults who have an inadequate response to or cannot tolerate hydroxyurea.
3. Graft-versus-Host Disease (GVHD)
Used for certain patients with steroid-refractory acute or chronic GVHD.

⚠️ Important: Ruxolitinib is a specialized medicine and is not suitable for self-medication. A hematologist/qualified physician should determine whether it is appropriate for an individual patient.

✅ Order From Get's Al Shifa .
🌍 website: dcenbd.com
📞 WhatsApp Us: +8801575308158

02/09/2026

Upajak ( ) 15 mg.

Rheumatoid Arthritis (RA): Helps reduce joint inflammation, pain, stiffness, and swelling.
Psoriatic Arthritis (PsA): Helps control inflammation and improve joint symptoms.
Atopic Dermatitis (Eczema): Used for moderate-to-severe atopic dermatitis in appropriate patients.
Ulcerative Colitis (UC): Helps induce and maintain remission in eligible patients.
Crohn’s Disease: Used for moderate-to-severe Crohn’s disease in appropriate patients.
Mechanism: A selective JAK1 inhibitor that modulates inflammatory signaling involved in these conditions.

Pharmaceutical Supply
B2B Enquiries, Worldwide Buyers & Distributors Welcome to Al Shifa.

For Order Form us WhatsApp us: +8801575308158

Visit website: dcenbd.com

01/09/2026

NIRANIB ( ) 100 mg Capsules

A PARP Inhibitor for Maintenance Therapy in Ovarian Cancer

Key Uses & Clinical Role:
Used as maintenance therapy for eligible adults with advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer.

May be used following a complete or partial response to platinum-based chemotherapy, according to the approved indication.

In the first-line setting, current U.S. labeling specifies HRD-positive disease, including qualifying BRCA mutations and/or genomic instability.

Also indicated for certain patients with recurrent germline BRCA-mutated ovarian, fallopian tube, or primary peritoneal cancer following response to platinum-based chemotherapy.

Niraparib works by inhibiting PARP-1 and PARP-2, enzymes involved in DNA repair, helping promote DNA damage in susceptible cancer cells.

Professional Note: Prescription oncology medicine. Patient selection, dosing, genetic/HRD testing and monitoring should be determined by a qualified oncology specialist.



Available From Al Shifa.
visit My Website: dcenbd.com
WhatsApp: +8801575308158